Related Experiment Video
Updated: Jun 7, 2026

Intranasal Administration of Recombinant Influenza Vaccines in Chimeric Mouse Models to Study Mucosal Immunity
Published on: June 25, 2015
Mumps resurgence in the United States
Vikas S Kancherla1, I Celine Hanson
1Allergy/Immunology Section, Department of Pediatrics, Texas Children's Hospital, Baylor College of Medicine, USA.
Abstract:
The recent mumps epidemic in the central United States has generated a large amount of public concern. A total of 2597 mumps cases have been reported in the United States in 11 states since January 1, 2006, representing a marked resurgence of mumps in a single year. The majority of these recent cases have occurred in college students age 18 to 25 years. Most were vaccinated with 2 doses of measles, mumps, and rubella-containing vaccines. Such outbreaks provide an opportunity for clinicians to review the clinical presentation, diagnosis, and morbidity of vaccine-preventable infections and also to review immunologic mechanisms and practice guidelines that might contribute to poor vaccine responses. A review of mumps is provided with discussion of potential mechanisms for vaccine failure.
Related Concept Videos
Viral Recombination
Vaccinations
Infectious Diseases and Their Occurrence
Smallpox
Chickenpox
Poliomyelitis

